PB1762: PONATINIB VERSUS IMATINIB WITH REDUCED-INTENSITY CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME–POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): PHALLCON STUDY
暂无分享,去创建一个
H. Dombret | M. Vignetti | E. Jabbour | D. Gómez-Almaguer | J. Ribera | Y. Minami | H. Kantarjian | M. Hennessy | G. Martinelli | A. Vorog | B. Wang